The 8-year old medical device company developed a procedure called “MAKOplasty” that uses robotic arms to perform orthopedic procedures and orthopedic implant surgery.
Yesterday, MAKO announced that their sales and guidance were lower than expected in Q2 and 2012 due to lower demand from hospitals due to lack of capital to purchase the relatively expensive surgical systems.. In Q2 they sold 9 surgical systems, 2 lower than analysts’ expectations. They lowered their guidance for the year to between 42 and 48 systems sales, lower than analysts’ expectations of 52 to 58 units.
David Cornes holds a degree in economics from the University of Montana.